PRESS RELEASE published on 07/24/2024 at 12:30, 2 years 2 months ago Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Experienced Pharmaceutical Executive Simona Skerjanec Immunic, Inc. strengthens its board with the appointment of experienced pharmaceutical executive Simona Skerjanec, known for leading successful commercial launches in MS therapy Board Appointment Immunic Inc. MS Therapy Simona Skerjanec Pharmaceutical Executive
BRIEF published on 07/09/2024 at 12:35, 2 years 3 months ago Immunic Appoints Jason Tardio as Chief Operating Officer and President Multiple Sclerosis Immunic Vidofludimus Calcium COO Appointment Jason Tardio
BRIEF published on 07/09/2024 at 12:35, 2 years 3 months ago Immunic nomme Jason Tardio au poste de directeur de l'exploitation et président Sclérose En Plaques Vidofludimus Calcium Nomination Du COO Immunitaire Jason Tardio
PRESS RELEASE published on 07/09/2024 at 12:30, 2 years 3 months ago Immunic Appoints Jason Tardio as Chief Operating Officer and President Immunic appoints Jason Tardio as Chief Operating Officer and President, bringing extensive multiple sclerosis drug commercialization experience. Werner Gladdines promoted to Chief Development Officer Chief Operating Officer Multiple Sclerosis Immunic Jason Tardio Werner Gladdines
BRIEF published on 05/28/2024 at 12:35, 2 years 4 months ago Immunic to Participate in Industry and Scientific Conferences in June Biotechnology Investor Relations Conférences Chronic Diseases Scientific Engagement
BRIEF published on 05/28/2024 at 12:35, 2 years 4 months ago Immunic participera à des conférences industrielles et scientifiques en juin Biotechnologie Conférences Relations Avec Les Investisseurs Maladies Chroniques Engagement Scientifique
PRESS RELEASE published on 05/28/2024 at 12:30, 2 years 4 months ago Immunic to Participate in Industry and Scientific Conferences in June Immunic, Inc. (Nasdaq: IMUX) will participate in BIO International Convention 2024 and PCMG Assembly 2024 in June to present clinical pipeline of therapies for chronic inflammatory and autoimmune diseases Clinical Pipeline Immunic Inc IMUX BIO International Convention 2024 PCMG Assembly 2024
BRIEF published on 05/08/2024 at 12:35, 2 years 5 months ago Immunic, Inc. Announces Q1 2024 Financial Results and Corporate Updates Financial Strategy Immunic Inc Q1 2024 Financial Report Multiple Sclerosis Trials Celiac Disease Treatment
BRIEF published on 05/08/2024 at 12:35, 2 years 5 months ago Immunic, Inc. annonce ses résultats financiers du premier trimestre 2024 et des mises à jour sur l'entreprise Stratégie Financière Immunic Inc Rapport Financier Du Premier Trimestre 2024 Essais Sur La Sclérose En Plaques Traitement De La Maladie Coeliaque
PRESS RELEASE published on 05/08/2024 at 12:30, 2 years 5 months ago Immunic, Inc. Reports First Quarter 2024 Financial Results and Provides Corporate Update Immunic, Inc. reports first quarter 2024 financial results, including capital increase and progress in MS and gastrointestinal disease therapies Financial Results Clinical Trials Immunic Inc. Gastrointestinal Disease MS Therapy
Published on 10/10/2026 at 04:45, 12 hours 51 minutes ago Immutable Holdings and Jorge Masvidal's Gamebred Fighting Championship (FC) Enter Into Definitive Agreement for Proposed Reverse Takeover Transaction and Listing on the TSXV
Published on 10/10/2026 at 02:03, 15 hours 33 minutes ago BrandPilot AI Announces Closing of Previously Announced Debt Settlement
Published on 10/10/2026 at 02:00, 15 hours 36 minutes ago Battery X Metals Reports Estimated Driving Range Increase of Approximately 101 Kilometers Following a Single-Electric-Vehicle Performance Evaluation of Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Technology
Published on 10/09/2026 at 23:00, 18 hours 36 minutes ago Trans Canada Gold Closes First Tranche of Non-Brokered Private Placement for Gross Proceeds of CDN $2,144,720
Published on 10/09/2026 at 22:15, 19 hours 21 minutes ago Loop Industries to Host Second Quarter Fiscal 2027 Earnings Conference Call
Published on 10/10/2026 at 16:35, 1 hour 1 minute ago New Opportunities for Global Cooperation: Kexing Biopharm Shines at CPHI Milan 2026
Published on 10/10/2026 at 16:30, 1 hour 6 minutes ago ZPMC-Built Infrastructure Supports China's First Offshore Wind Project to Deploy 18 MW Turbines at Scale
Published on 10/10/2026 at 10:05, 7 hours 31 minutes ago ONLYOFFICE 10.0 brings AI tools, modular apps, and stronger security to its open-source office suite
Published on 10/09/2026 at 21:24, 20 hours 11 minutes ago Branicks Group AG: Extraordinary General Meeting does not approve all items on the agenda
Published on 10/09/2026 at 21:17, 20 hours 18 minutes ago EQS-Adhoc: Branicks Group AG: Agenda topic four at extraordinary general meeting rejected
Published on 10/09/2026 at 19:27, 22 hours 9 minutes ago Disclosure of transactions in own shares from October 1 to October 9, 2026
Published on 10/09/2026 at 19:27, 22 hours 9 minutes ago Déclaration hebdomadaire d'opérations effectuées du 1er au 9 octobre 2026
Published on 10/09/2026 at 17:45, 23 hours 51 minutes ago Déclaration des droits de vote à fin septembre 2026
